BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9406964)

  • 1. Brain structures involved in the behavioral stimulant effect of central serotonin release.
    Vanderwolf CH; McLauchlin M; Dringenberg HC; Baker GB
    Brain Res; 1997 Oct; 772(1-2):121-34. PubMed ID: 9406964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of serotonergic stimulation on hippocampal and neocortical slow waves and behavior.
    Robertson B; Baker GB; Vanderwolf CH
    Brain Res; 1991 Aug; 555(2):265-75. PubMed ID: 1933339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological studies on serotonin-mediated behaviour.
    Green AR
    J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor effects of serotonin in the central nervous system.
    Gerson SC; Baldessarini RJ
    Life Sci; 1980 Oct; 27(16):1435-51. PubMed ID: 6160367
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice.
    Villégier AS; Salomon L; Blanc G; Godeheu G; Glowinski J; Tassin JP
    Eur J Neurosci; 2006 Sep; 24(5):1359-65. PubMed ID: 16965547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic properties of serotonergic agents and antidepressant drugs.
    Fuller RW
    J Clin Psychiatry; 1987 Mar; 48 Suppl():5-11. PubMed ID: 3493240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rats.
    Van de Kar LD; Wilkinson CW; Ganong WF
    J Pharmacol Exp Ther; 1981 Oct; 219(1):85-90. PubMed ID: 6457138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a role of brain serotonergic neurotransmission in avoidance learning.
    Ogren SO
    Acta Physiol Scand Suppl; 1985; 544():1-71. PubMed ID: 3006431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
    McElroy JF; Miller JM; Meyer JS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA.
    Green AR; Kelly PH
    Br J Pharmacol; 1976 May; 57(1):141-7. PubMed ID: 1276533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of tranylcypromine on glycogenolysis in the rat brain].
    Rinaudo MT; Curto M; Bruno R; Torre E; Bogetto F; Torre M
    Boll Soc Ital Biol Sper; 1979 Jan; 55(2):148-52. PubMed ID: 17955640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of brain monoamine and locomotor activity in rats.
    Foldes A; Costa E
    Biochem Pharmacol; 1975 Sep; 24(17):1617-21. PubMed ID: 1191320
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonergic measures in blood and brain and their correlations in rats treated with tranylcypromine, a monoamine oxidase inhibitor.
    Malyszko J; Urano T; Serizawa K; Yan D; Kozima Y; Takada Y; Takada A
    Jpn J Physiol; 1993; 43(5):613-26. PubMed ID: 7511710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of a rat behavioral model for serotonin receptor activation.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):339-47. PubMed ID: 682117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thiophene analogues of chloroamphetamines on central serotonergic mechanisms.
    Conde S; Madroñero R; Fernández-Tomé MP; del Río J
    J Med Chem; 1978 Sep; 21(9):978-81. PubMed ID: 722762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of diphenylhydantoin on brain 5-hydroxytryptamine metabolism and function.
    Green AR; Grahame-Smith DG
    Neuropharmacology; 1975 Feb; 14(2):107-13. PubMed ID: 1153078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.